āĻšā§āĻŽNZYM âĸ VIE
add
Novozymes A/S
ā§Ģā§.ā§Šā§ŦâŦ
ā§ āĻŽā§, ā§Ģ:ā§Ģā§Ļ:ā§Ļā§Ģ PM GMT +⧍ · EUR · VIE · āĻĄāĻŋāϏāĻā§āϞā§āĻŽāĻžāϰ
āĻāĻžāϞ āĻļā§āώ āϝ⧠āĻĻāĻžāĻŽā§ āĻāĻŋāϞ
ā§Ģā§.ā§Šā§ĒâŦ
āϏāĻžāϰāĻž āĻĻāĻŋāύā§āϰ āĻā§āϰā§āĻĄāĻŋāĻā§ā§ āϏā§āĻāĻā§āϰ āĻĻāĻžāĻŽā§āϰ āĻāĻ āĻž āύāĻžāĻŽāĻžāϰ āϰā§āĻā§āĻ
ā§Ģā§.⧍ā§ĒâŦ - ā§Ģā§.ā§Ģ⧍âŦ
āϏāĻžāϰāĻž āĻŦāĻāϰā§āϰ āϰā§āĻā§āĻ
ā§Ģā§Ļ.⧧⧍âŦ - ā§Ŧā§Ģ.ā§Ļā§ĒâŦ
āĻŽāĻžāϰā§āĻā§āĻ āĻā§āϝāĻžāĻĒ
ā§§ā§ā§.ā§Ļ⧝āĻā§ DKK
āĻāĻĄāĻŧ āĻāϞāĻŋāĻāĻŽ
ā§Ē.ā§Ļā§Ļ
P/E āĻ
āύā§āĻĒāĻžāϤ
-
āϞāĻā§āϝāĻžāĻāĻļ āĻĒā§āϰāĻĻāĻžāύ
-
āĻĒā§āϰāĻžāĻāĻŽāĻžāϰāĻŋ āĻāĻā§āϏāĻā§āĻā§āĻ
CPH
āĻŦāĻžāĻāĻžāϰ āϏāĻāĻŦāĻžāĻĻ
āĻĢāĻžāĻāύāĻžāύā§āϏāĻŋā§āĻžāϞ āĻĒāĻžāϰāĻĢāϰā§āĻŽā§āϝāĻžāύā§āϏ
āĻā§ā§āϰ āϏā§āĻā§āĻāĻŽā§āύā§āĻ
āĻāĻĒāĻžāϰā§āĻāύ
āύā§āĻ āĻāύāĻāĻžāĻŽ
(EUR) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ēinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻāĻĒāĻžāϰā§āĻāύ | ā§§ā§Ļā§Ļ.ā§Ļā§¯Â āĻā§ | -ā§ā§Ž.⧍ā§Ŧ% |
āĻŦā§āϝāĻŦāϏāĻž āĻāĻžāϞāĻžāύā§āϰ āĻāϰāĻ | ā§Šā§Ļ.ā§Šā§Ģ āĻā§ | -ā§ā§Ž.ā§Ģā§Ž% |
āύā§āĻ āĻāύāĻāĻžāĻŽ | ⧧⧍.ā§§ā§Ļ āĻā§ | -ā§Žā§¨.ā§Ŧā§% |
āύā§āĻ āĻĒā§āϰāĻĢāĻŋāĻ āĻŽāĻžāϰā§āĻāĻŋāύ | ⧧⧍.ā§Ļā§Ž | -⧍ā§Ļ.ā§Šā§¨% |
āĻļā§ā§āĻžāϰ āĻĒā§āϰāϤāĻŋ āĻāĻĒāĻžāϰā§āĻāύ | â | â |
EBITDA | ā§Šā§Ŧ.⧝ā§Ģ āĻā§ | -ā§Ŧ⧝.ā§Ģā§Ē% |
āĻĒā§āϰāϝā§āĻā§āϝ āĻā§āϝāĻžāĻā§āϏā§āϰ āĻšāĻžāϰ | ⧍ā§Ŧ.ā§Ļā§Ģ% | â |
āĻŦā§āϝāĻžāϞā§āύā§āϏ āĻļāĻŋāĻ
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ
āĻŽā§āĻ āĻĻāĻžā§
(EUR) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ēinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āĻā§āϝāĻžāĻļ āĻ āĻāĻŽ āϏāĻŽā§ā§āϰ āĻŦāĻŋāύāĻŋā§ā§āĻ | ā§¨ā§Ž.ā§Ļā§Ļ āĻā§ | -ā§ā§Ē.⧝⧧% |
āĻŽā§āĻ āϏāĻŽā§āĻĒāĻĻ | ā§§ā§Ģ.⧍ā§ĻāĻļāĻ¤Â āĻā§ | -ā§Ēā§Ŧ.ā§Ēā§Ž% |
āĻŽā§āĻ āĻĻāĻžā§ | ā§Ēā§Ļā§§.⧝ā§Ŧ āĻā§ | -ā§ā§§.ā§Šā§% |
āĻŽā§āĻ āĻāĻā§āĻāĻāĻŋ | ā§§ā§§.ā§§ā§ŽāĻļāĻ¤Â āĻā§ | â |
āĻāĻāĻāϏā§āĻā§āϝāĻžāύā§āĻĄāĻŋāĻ āĻļā§ā§āĻžāϰ | ⧍ā§.ā§ā§¯Â āĻā§ | â |
āĻĒā§āϰāĻžāĻāϏ āĻā§ āĻŦā§āĻ āϰā§āĻļāĻŋāĻ | ā§§.ā§Ēā§Š | â |
āϏāĻŽā§āĻĒāĻĻ āĻĨā§āĻā§ āĻā§ | ā§Ģ.ā§§ā§Ļ% | â |
āĻŽā§āϞāϧāύ āĻĨā§āĻā§ āĻā§ | ā§Ģ.⧝ā§% | â |
āĻā§āϝāĻžāĻļ āĻĢā§āϞā§
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ
(EUR) | āĻĄāĻŋāϏ⧠⧍ā§Ļ⧍ā§Ēinfo | Y/Y āĻĒāϰāĻŋāĻŦāϰā§āϤāύ |
---|---|---|
āύā§āĻ āĻāύāĻāĻžāĻŽ | ⧧⧍.ā§§ā§Ļ āĻā§ | -ā§Žā§¨.ā§Ŧā§% |
āĻ
āĻĒāĻžāϰā§āĻļāύ āĻĨā§āĻā§ āĻĒāĻžāĻā§āĻž āĻā§āϝāĻžāĻļ | ⧍ā§Ē.ā§Ģā§¯Â āĻā§ | -ā§ā§Ž.ā§Ļā§Ž% |
āĻŦāĻŋāύāĻŋā§ā§āĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§.⧍ā§Ē āĻā§ | ā§Žā§.⧝⧝% |
āĻĢāĻžāĻāύā§āϝāĻžāύā§āϏāĻŋāĻ āĻĨā§āĻā§ āĻĒā§āϰāĻžāĻĒā§āϤ āĻā§āϝāĻžāĻļ | -ā§§ā§Ŧ.ā§Ēā§¯Â āĻā§ | ā§ā§Ļ.⧍⧝% |
āύāĻāĻĻā§ āĻŽā§āĻ āĻĒāϰāĻŋāĻŦāϰā§āϤāύ | ⧝ā§Ŧ.ā§Ļā§Ļ āϞāĻž | ā§§ā§§ā§Ŧ.⧍ā§% |
āĻĢā§āϰāĻŋ āĻā§āϝāĻžāĻļ āĻĢā§āϞ⧠| ⧧⧝.ā§Ģā§Ŧ āĻā§ | -ā§ā§¨.ā§ā§Ž% |
āϏāĻŽā§āĻĒāϰā§āĻā§
Novozymes A/S was a global biotechnology company headquartered in BagsvÃĻrd, outside of Copenhagen, Denmark. The company's focus was the research, development and production of industrial enzymes, microorganisms, and biopharmaceutical ingredients. The company merged with Chr. Hansen to form Novonesis in January 2024.
Prior to the merger, the company had operations around the world, including in China, India, Brazil, Argentina, United Kingdom, the United States, and Canada. Class B shares of its stock were listed on the NASDAQ OMX Nordic exchange. Wikipedia
āϏāĻŋāĻāĻ
āϏā§āĻĨāĻžāĻĒāĻŋāϤ āĻšā§ā§āĻā§
⧍ā§Ļā§Ļā§Ļ
āĻā§ā§āĻŦāϏāĻžāĻāĻ
āĻāϰā§āĻŽāĻāĻžāϰā§
ā§§ā§Ļ,ā§Ģā§Žā§¨